fludeoxyglucose f18

Generic: fludeoxyglucose f18

Labeler: the university of texas md anderson cancer center
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fludeoxyglucose f18
Generic Name fludeoxyglucose f18
Labeler the university of texas md anderson cancer center
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

fludeoxyglucose f-18 300 mCi/mL

Manufacturer
The University of Texas MD Anderson Cancer Center

Identifiers & Regulatory

Product NDC 60215-411
Product ID 60215-411_4041af0a-011f-ddc6-e063-6394a90af478
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203246
Listing Expiration 2026-12-31
Marketing Start 2011-12-06

Pharmacologic Class

Established (EPC)
radioactive diagnostic agent [epc]
Mechanism of Action
radiopharmaceutical activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 60215411
Hyphenated Format 60215-411

Supplemental Identifiers

UNII
0Z5B2CJX4D
NUI
N0000177914 N0000000205

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fludeoxyglucose f18 (source: ndc)
Generic Name fludeoxyglucose f18 (source: ndc)
Application Number ANDA203246 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 300 mCi/mL
source: ndc
Packaging
  • 27 mL in 1 VIAL, GLASS (60215-411-30)
source: ndc

Packages (1)

60215-411-30 27 mL in 1 VIAL, GLASS (60215-411-30)

Ingredients (1)

fludeoxyglucose f-18 (300 mCi/mL)

Linked Drug Pages (1)

Fludeoxyglucose F18 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "4041af0a-011f-ddc6-e063-6394a90af478", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["43954e40-bb95-4275-92ab-96211b7de907"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["The University of Texas MD Anderson Cancer Center"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "27 mL in 1 VIAL, GLASS (60215-411-30)", "package_ndc": "60215-411-30", "marketing_start_date": "20111206"}], "brand_name": "Fludeoxyglucose F18", "product_id": "60215-411_4041af0a-011f-ddc6-e063-6394a90af478", "dosage_form": "INJECTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "60215-411", "generic_name": "Fludeoxyglucose F18", "labeler_name": "The University of Texas MD Anderson Cancer Center", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose", "brand_name_suffix": "F18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "300 mCi/mL"}], "application_number": "ANDA203246", "marketing_category": "ANDA", "marketing_start_date": "20111206", "listing_expiration_date": "20261231"}